An Open-label Phase I/II Study of KX2-391 in Combination With Paclitaxel in Patients With Advanced Solid Tumors
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Tirbanibulin (Primary) ; Paclitaxel
- Indications Advanced breast cancer; Gastric cancer; Solid tumours
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 15 Jan 2013 New source identified and integrated (ClinicalTrials.gov record NCT01764087).
- 07 Jan 2013 Planned End Date changed to 1 May 2016, as reported by ClinicalTrials.gov.
- 07 Jan 2013 Planned initiation date changed to 1 Dec 2012, as reported by ClinicalTrials.gov.